STERIS (STE) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Overweight | $275.00 from $270.00 | Aug 7, 2026 |
| UBS | Maintained | Buy | $270.00 from $275.00 | Aug 7, 2026 |
| UBS | Initiated Coverage | Buy | $275.00 | Jul 28, 2026 |
| Keybanc | Maintained | Overweight | $269.00 from $291.00 | May 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $295.00 from $276.00 | Aug 8, 2025 |
| Keybanc | Maintained | Overweight | $288.00 from $277.00 | Jul 22, 2025 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $276.00 from $260.00 | Jul 15, 2025 |
| Jefferies | Initiated Coverage | Hold | $263.00 | May 29, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $260.00 from $240.00 | May 19, 2025 |
| JMP Securities | Maintained | Market Outperform | $280.00 from $265.00 | May 16, 2025 |
| Stephens & Co. | Maintained | Overweight | $250.00 | May 15, 2025 |
| JMP Securities | Maintained | Market Outperform | $265.00 | Apr 10, 2025 |
| Needham | Maintained | Hold | — | Apr 7, 2025 |
| Stephens & Co. | Maintained | Overweight | $240.00 | Feb 6, 2025 |
| JMP Securities | Maintained | Market Outperform | $265.00 | Feb 6, 2025 |
| Piper Sandler | Maintained | Overweight | $265.00 from $260.00 | Feb 3, 2025 |
| JMP Securities | Maintained | Market Outperform | $265.00 | Nov 18, 2024 |
| Needham | Maintained | Hold | — | Nov 8, 2024 |
| Stephens & Co. | Maintained | Overweight | $260.00 | Nov 7, 2024 |
| Piper Sandler | Upgraded | Neutral → Overweight | $260.00 from $230.00 | Oct 24, 2024 |
Frequently asked questions
Is STE a buy, sell, or hold?
Analysts covering STERIS currently average a Buy rating: 8 buy, 4 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on STE?
On Aug 7, 2026, Piper Sandler maintained STERIS at Overweight with a price target of $275.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.